In what’s shaping up as a year of oversized paydays for chief executives, Gilead Sciences CEO John Martin has emerged as one of 2013’s biggest winners.
Martin pulled in compensation valued at nearly $180 million in 2013, including stock option gains worth $158 million, the biotech giant said Friday. Martin received $15.4 million in salary, incentive awards, stock and stock options -- about what he’s made in each of the past three fiscal years. But he cashed in on stock options for a $158.9 million gain and received another $4.8 million from shares that vested last year, Gilead said in a preliminary proxy filing.
Help employers find you! Check out all the jobs and post your resume.
